14132 Federal Register / Vol. 74, No. 59 / Monday, March 30, 2009 / Notices 

Research Dissertation, Panel H, FOA PAR07– 

231.’’ 

For More Information Contact: Maurine F. 

Goodman, M.A., M.P.H., Scientific Review 

Officer, Office of the Director, Office of the 

Chief Science Officer, CDC, 1600 Clifton 

Road, NE., Mailstop D72, Atlanta, GA 30333, 

Telephone: (404) 639–4640. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 23, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–6989 Filed 3–27–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Strengthening 

Infectious Disease Research Capacity 

for Public Health Action in Guatemala 

and Central America, Funding 

Opportunity Announcement (FOA) 

GH09–001 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 2 p.m.–5 p.m., April 30, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of applications received in 

response to ‘‘Strengthening Infectious 

Disease Research Capacity for Public Health 

Action in Guatemala and Central America, 

FOA GH09–001.’’ 

For Further Information Contact: Maurine 

F. Goodman, M.A., M.P.H., Scientific Review 

Officer, Office of the Director, Office of the 

Chief Science Officer, CDC, 1600 Clifton 

Road, NE., Mailstop D74, Atlanta, GA 30333, 

Telephone: (404) 639–4640. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 20, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office Centers for Disease Control and 

Prevention. 

[FR Doc. E9–6990 Filed 3–27–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control 

Special Emphasis Panel (SEP): CDC 

Grants for Public Health Research 

Dissertation, Panel D, Funding 

Opportunity Announcement (FOA) 

PAR07–231 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 9 p.m.–5 a.m., May 14, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of applications received in 

response to ‘‘CDC Grants for Public Health 

Research Dissertation, Panel D, FOA PAR07– 

231.’’ 

Contact Person for More Information: 

Susan B. Stanton, D.D.S., Scientific Review 

Officer, Office of the Director, Office of the 

Chief Science Officer, CDC, 1600 Clifton 

Road, NE., Mailstop D72, Atlanta, GA 30333, 

Telephone: (404) 639–4640. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 23, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–7010 Filed 3–27–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Addressing 

Emerging Infectious Diseases in 

Bangladesh, Funding Opportunity 

Announcement (FOA) Number CI 09– 

002 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 12 p.m.–2 p.m., May 6, 

2009 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of an application received in 

response to ‘‘Addressing Emerging Infectious 

Diseases in Bangladesh, FOA CI 09–002.’’ 

Contact Person for More Information: 

Gregory Anderson, M.P.H., M.S., Scientific 

Review Administrator, Strategic Science and 

Program Unit, Office of the Director, 

Coordinating Center for Infectious Diseases, 

CDC, 1600 Clifton Road, Mailstop E–60, 

Atlanta, GA 30333, Telephone: (404) 498– 

2275. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: March 23, 2009. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. E9–7012 Filed 3–27–09; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): CDC Grants for 

Public Health Research Dissertation, 

Panel E, Funding Opportunity 

Announcement (FOA) PAR07–231 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 


sroberts on PROD1PC70 with NOTICES